These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35935586)

  • 1. SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.
    Delgado JF; Vidal-Pla M; Moya MC; Espasa M; Casabella A; Seda M; Calvet J; Gratacós J; Serrano RM; Peña P
    J Immunol Res; 2022; 2022():8287087. PubMed ID: 35935586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study.
    Brlić PK; Pavletić M; Lerga M; Krstanović F; Matešić MP; Miklić K; Malić S; Mikša L; Pajcur M; Peruč D; Schubert M; Bertoglio F; Arapović J; Protić A; Šustić A; Milošević M; Šain LČ; Jonjić S; Lisnić VJ; Brizić I
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.
    McNaughton AL; Paton RS; Edmans M; Youngs J; Wellens J; Phalora P; Fyfe A; Belij-Rammerstorfer S; Bolton JS; Ball J; Carnell GW; Dejnirattisai W; Dold C; Eyre DW; Hopkins P; Howarth A; Kooblall K; Klim H; Leaver S; Lee LN; López-Camacho C; Lumley SF; Macallan DC; Mentzer AJ; Provine NM; Ratcliff J; Slon-Compos J; Skelly D; Stolle L; Supasa P; Temperton N; Walker C; Wang B; Wyncoll D; ; ; Simmonds P; Lambe T; Baillie JK; Semple MG; Openshaw PJ; ; Obolski U; Turner M; Carroll M; Mongkolsapaya J; Screaton G; Kennedy SH; Jarvis L; Barnes E; Dunachie S; Lourenço J; Matthews PC; Bicanic T; Klenerman P; Gupta S; Thompson CP
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological Screening of Immunoglobulin G against SARS-CoV-2 Nucleocapsid and Spike Protein before and after Two Vaccine Doses among Healthcare Workers in Japan.
    Hiramoto S; Miyashita D; Kimura T; Niwa T; Uchida A; Sano M; Murata M; Nagasawa T; Tsunekawa K; Aoki T; Yoshida A; Kato T; Yanagisawa K; Tokue Y; Murakami M
    Tohoku J Exp Med; 2022 May; 257(1):57-64. PubMed ID: 35354694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model.
    Rak A; Gorbunov N; Kostevich V; Sokolov A; Prokopenko P; Rudenko L; Isakova-Sivak I
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants.
    Lin WS; Chen IC; Chen HC; Lee YC; Wu SC
    Front Immunol; 2021; 12():795741. PubMed ID: 34925381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals.
    Ogrič M; Žigon P; Podovšovnik E; Lakota K; Sodin-Semrl S; Rotar Ž; Čučnik S
    Front Immunol; 2022; 13():876533. PubMed ID: 35711413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects.
    Maniscalco GT; Manzo V; Ferrara AL; Perrella A; Di Battista M; Salvatore S; Graziano D; Viola A; Amato G; Moreggia O; Di Giulio Cesare D; Barbato S; Servillo G; Longo K; Di Giovanni M; Scarpati B; Muggianu SM; Longo G; Russo G; Andreone V; De Rosa V
    Mult Scler Relat Disord; 2022 Feb; 58():103455. PubMed ID: 34929455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
    Yahi N; Chahinian H; Fantini J
    J Infect; 2021 Nov; 83(5):607-635. PubMed ID: 34384810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.
    Feng W; Xiang Y; Wu L; Chen Z; Li Q; Chen J; Guo Y; Xia D; Chen N; Zhang L; Zhu S; Zhao KN
    J Clin Lab Anal; 2022 Jun; 36(6):e24479. PubMed ID: 35527696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting.
    Lim HX; Masomian M; Khalid K; Kumar AU; MacAry PA; Poh CL
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin.
    Pušnik J; Zorn J; Monzon-Posadas WO; Peters K; Osypchuk E; Blaschke S; Streeck H
    Nat Commun; 2024 Apr; 15(1):3102. PubMed ID: 38600072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.